欧洲急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

2022年欧洲急性胰臟炎市值为14.921亿美元，预计到2030年将达到22.6069亿美元；预计 2022 年至 2030 年CAGR为 5.3%。

急性胰臟炎后糖尿病发生率上升推动欧洲急性胰臟炎市场

胰臟产生胰岛素，一种调节血糖水平的荷尔蒙。胰臟炎会损害胰臟产生胰岛素的细胞，进而导致急性胰臟炎患者罹患糖尿病。患有急性胰臟炎的人患糖尿病的风险是一般人群的两倍。在急性胰臟炎的各种严重程度中都观察到糖尿病后遗症，并且可能伴随其他临床併发症。

根据2022年发布的《欧洲医学和药理学科学评论》，西方糖尿病人群中胰源性糖尿病的盛行率为5-10%，其中慢性胰臟炎占20%，急性胰臟炎占80%。根据 2021 年国家医学图书馆发表的一篇文章，约 23% 的急性胰臟炎患者可能在出院三年内患有糖尿病。此外，2020 年《胃肠病学杂誌》上发表的一篇文章指出，急性胰臟炎后，约有3%、7%、9% 和11% 的患者在出院6、12、18 和24 个月时分别发展为糖尿病。根据 MDPI 发表的一篇文章，到 2023 年，约 40% 的急性胰臟炎患者受到糖尿病前期和糖尿病的影响，死亡和再入院的风险比第 2 型糖尿病患者更高。此外，大约 60.2% 的成人患者在急性胰臟炎后发展为糖尿病，9% 的儿童在急性復发性胰臟炎或慢性胰臟炎后发展为糖尿病，而且这种风险随着年龄的增长而增加。研究人员在一项比较重症和轻度急性胰臟炎的统合分析中发现，重症急性胰臟炎后糖尿病的发生率（约 39%）高于轻度急性胰臟炎（14%）。因此，急性胰臟炎患者或復健患者中糖尿病发病率的增加促进了欧洲急性胰臟炎市场的成长。

欧洲急性胰臟炎市场概况

欧洲急性胰臟炎市场分为德国、英国、法国、义大利、西班牙、北欧国家、荷兰和欧洲其他国家。德国和英国等国家预计将成为该地区市场的最大贡献者。急性胰臟炎盛行率的上升和酒精消费的增加是推动欧洲市场成长的主要因素。根据联邦统计局的数据，2019年德国的医疗支出达4,600.3亿美元。由于其创新的医疗保健方法，对于提供急性胰臟炎治疗产品的公司来说，这是一个有吸引力的市场。德国的医疗器材製造商还可以为各种研究计画寻求政府资助，并获得德国復兴信贷银行 (KfW) 的资助。製造商越来越关注新产品开发和策略合作，以开发急性胰臟炎等先进诊断设备，预计将在未来几年进一步推动市场成长。

欧洲急性胰臟炎市场收入及 2030 年预测（百万美元）

欧洲急性胰臟炎市场细分

欧洲急性胰臟炎市场按产品、原因、最终用户和国家进行细分。

根据产品类型，欧洲急性胰臟炎市场分为药物、诊断等。 2022年，诊断细分市场占据最大市场份额。

根据方法，欧洲急性胰臟炎市场分为胆结石、酗酒、遗传性疾病、感染等。 2022 年，胆结石细分市场占据最大的市场份额。

根据最终用户，欧洲急性胰臟炎市场分为医院、诊断实验室、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

根据国家/地区，欧洲急性胰臟炎市场分为英国、德国、法国、义大利、西班牙、北欧国家、荷兰和欧洲其他国家。 2022年，德国在欧洲急性胰臟炎市场份额中占据主导地位。

Abbott Laboratories、Actim Oy、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是欧洲急性胰臟炎市场上的一些领先公司。

主要市场驱动因素
- 急性胰臟炎导致胰臟癌病例增加
- 急性胰臟炎后糖尿病发生率上升
主要市场限制
- 胰臟炎和胰臟癌治疗的副作用
主要市场机会
- 急性胰臟炎的研发活动和宣传项目数量激增
未来的趋势
- 特异性急性胰臟炎治疗的进展
影响分析：

第 6 章：急性胰臟炎市场 - 欧洲市场分析

欧洲急性胰臟炎市场收入，2022 - 2030

第 7 章：欧洲急性胰臟炎市场 - 收入和 2030 年预测 - 按产品分类

概述
2022 年及 2030 年欧洲急性胰臟炎市场收入份额（按产品划分）（%）
药物
诊断
其他的

第 8 章：欧洲急性胰臟炎市场 - 收入和 2030 年预测 - 按原因

概述
2022 年及 2030 年欧洲急性胰臟炎市场收入份额（按原因划分）（%）
胆结石
酗酒
遗传性疾病
感染
其他的

第 9 章：欧洲急性胰臟炎市场 - 收入和 2030 年预测 - 按最终用户

概述
2022 年及 2030 年欧洲急性胰臟炎市场收入份额（按最终用户）（%）
医院
诊断实验室
门诊手术中心
其他的

第 10 章：欧洲急性胰臟炎市场 - 国家分析

概述

第 11 章：欧洲急性胰臟炎市场-产业格局

概述
欧洲急性胰臟炎市场的成长策略
无机成长策略
- 概述
有机成长策略
- 概述

第 12 章：公司简介

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Actim Oy
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

第 13 章：附录

Product Code: BMIRE00029223

The Europe acute pancreatitis market was valued at US$ 1,492.10 million in 2022 and is expected to reach US$ 2,260.69 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Rising Incidence of Diabetes Following Acute Pancreatitis Fuels the Europe Acute Pancreatitis Market

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5-10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the Europe acute pancreatitis market.

Europe Acute Pancreatitis Market Overview

The Europe acute pancreatitis market is segmented into Germany, the UK, France, Italy, Spain, Nordic Countries, The Netherlands, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of acute pancreatitis and increase in alcohol consumption are the major factors driving the market growth in Europe. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 460.03 billion in 2019. It is an attractive market for companies offering therapeutic products for acute pancreatitis due to its innovative approach toward healthcare. Medical device manufacturers in Germany can also seek government funding for a variety of research projects and receive grants from the Kreditanstalt fur Wiederaufbau (KfW). The increasing focus of manufacturers on new product development and strategic collaborations to develop advanced diagnostic devices such as acute pancreatitis is expected to further propel the market growth in the coming years.

Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Europe Acute Pancreatitis Market Segmentation

The Europe acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Europe acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Europe acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Europe acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe acute pancreatitis market is segmented into the U.K., Germany, France, Italy, Spain, the Nordic Countries, the Netherlands, and the Rest of Europe. Germany dominated the Europe acute pancreatitis market share in 2022.

Abbott Laboratories, Actim Oy, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Europe acute pancreatitis market.

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - Europe Market Analysis

6.1 Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Europe Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Europe Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. Europe Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Europe Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Actim Oy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Fresenius Kabi AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

List Of Tables

Table 1. Europe Acute Pancreatitis Market Segmentation
Table 2. Europe Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. France: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. France: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Nordic Region: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 30. Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 31. Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 32. Nordic Region: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 33. Nordic Region: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Netherlands: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 35. Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 36. Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 37. Netherlands: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 38. Netherlands: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Europe: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 40. Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 44. Recent Inorganic Growth Strategies in the Europe Acute Pancreatitis Market
Table 45. Recent Organic Growth Strategies in the Europe Acute Pancreatitis Market
Table 46. Glossary of Terms, Europe Acute Pancreatitis Market

List Of Figures

Figure 1. Europe Acute Pancreatitis Market Segmentation, By Country
Figure 2. Europe Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 21. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in the Europe Acute Pancreatitis Market

欧洲急性胰臟炎市场预测至 2030 年 - 区域分析 - 按产品、原因和最终用户

Europe Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

第 4 章：欧洲急性胰臟炎市场格局

第 5 章：欧洲急性胰臟炎市场 - 主要产业动态